돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 38474생성일: 2026년 10월 23일

5-Bromonicotinamide → 5-{1'-tert-Butoxycarbonyl-4-oxospiro[chroman-2,4'-piperidin]-6-yl}nicotinamide

https://huagongshe.com/ko/reaction/38474

반응식

참여 물질

역할이름HCID투입량
반응물5-BromonicotinamideHCID 1808—
반응물Sodium CarbonateHCID 10340—
반응물1'-Tert-butoxycarbonyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[chroman-2,4'-piperidin]-4-oneHCID 57930961—
촉매HCID 178418397HCID 178418397—
용매WaterHCID 962—
용매ChloroformHCID 6212—
용매1,4-DioxaneHCID 31275—
생성물5-{1'-tert-Butoxycarbonyl-4-oxospiro[chroman-2,4'-piperidin]-6-yl}nicotinamideHCID 57931002—

반응 조건

온도100 °C

반응 단계

1′-tert-butoxycarbonyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[chroman-2,4′-piperidin]-4-one (1.43 g, 3.23 mmol), 5-bromonicotinamide (778 mg, 3.87 mmol), Pd(PPh3)4 (372 mg, 0.322 mmol), and aqueous 2M Na2CO3 (10 ml) solution were suspended in dioxane (20 ml) and heated at 100° C. for 4 h. The reaction mixture was diluted with CHCl3 and H2O, the aqueous layer was extracted with CHCl3. The combined organic layer was dried over MgSO4. The desiccant was removed through celite filtration and the filtrate was concentrated under reduced pressure. The resulting residue was purified through silica gel column chromatography (EtOAc/Acetone) to obtain the intended compound as a pale yellow foam.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08524730B2
출처 데이터셋uspto-grants-2013_09
ORD IDord-7e06f045e1ef42b1b489e3e145c87c11
출처 메모uspto-grants-2013_09